A Mother’s Intuition and the Long Road to Recovery: The Story of 2026 ACCO Ambassador Rylee’s Battle with Leukemia
admin The selection of four-year-old Rylee as a 2026 Ambassador for the American Childhood Cancer Organization...
admin
The Resilience of the Rare: How Genomic Research and Targeted Therapy Transformed the Prognosis for Ten-Year-Old Alice Lunde
The intersection of pediatric oncology and genomic research has reached a pivotal juncture, illustrated by...
CureSearch for Childrens Cancer Strengthens National Board with Appointment of Three Distinguished Industry Leaders
The national non-profit organization CureSearch for Children’s Cancer has officially announced the appointment of three...
Trailblazing Women: Celebrating Decades of Disruptive Innovation in Science and Cancer Research
During Women’s History Month, the Cancer Research Institute (CRI) proudly shines a spotlight on the...
Oricell Therapeutics Secures $110 Million in Pre-IPO Funding to Accelerate Groundbreaking Solid Tumor Cell Therapy Development
Shanghai-based Oricell Therapeutics, a burgeoning force in the biotechnology sector, has successfully closed a pre-initial...
Gold Ribbon Hero: Lily R – ACCO
The Clinical Presentation and Initial Diagnosis The diagnostic trajectory for Lily began when she was...
Resilience and Research: The Medical Journey of Fritz and the Evolving Landscape of Pediatric Ewing Sarcoma Treatment
The medical trajectory for nine-year-old Fritz began not in an oncology ward, but in a...
CureSearch Launches 2026 Community Impact Awards to Strengthen Psychosocial Support Systems for Pediatric Cancer Patients and Families
The national nonprofit organization CureSearch for Children’s Cancer has officially announced the launch of its...
Unlocking Immunotherapy’s Full Potential: Dr. Karin Pelka Pioneers AI-Driven Approach to Conquer Colorectal Cancer
Colorectal cancer (CRC), encompassing both colon and rectal cancers, represents a formidable challenge in modern...
FDA Rejects Replimune’s Melanoma Therapy Again Citing Unaddressed Study Concerns, Fueling Industry Debate
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
